Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling

Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Moazzam, Bahamondes, Luis, Bent Landoulsi, Sihem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752601/
https://www.ncbi.nlm.nih.gov/pubmed/29263025
http://dx.doi.org/10.9745/GHSP-D-17-00296
_version_ 1783290135059628032
author Ali, Moazzam
Bahamondes, Luis
Bent Landoulsi, Sihem
author_facet Ali, Moazzam
Bahamondes, Luis
Bent Landoulsi, Sihem
author_sort Ali, Moazzam
collection PubMed
description Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label).
format Online
Article
Text
id pubmed-5752601
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-57526012018-01-10 Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling Ali, Moazzam Bahamondes, Luis Bent Landoulsi, Sihem Glob Health Sci Pract Commentary Recently published evidence from 2 large studies find that the duration of effectiveness of the etonorgestrel-releasing contraceptive implant to be at least 5 years (compared with the current 3-year label), and for the 20 µg levonorgestrel-releasing intrauterine system at least 7 years (compared with the current 5-year label). Global Health: Science and Practice 2017-12-28 /pmc/articles/PMC5752601/ /pubmed/29263025 http://dx.doi.org/10.9745/GHSP-D-17-00296 Text en © Ali et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-17-00296
spellingShingle Commentary
Ali, Moazzam
Bahamondes, Luis
Bent Landoulsi, Sihem
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title_full Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title_fullStr Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title_full_unstemmed Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title_short Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
title_sort extended effectiveness of the etonogestrel-releasing contraceptive implant and the 20 µg levonorgestrel-releasing intrauterine system for 2 years beyond u.s. food and drug administration product labeling
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752601/
https://www.ncbi.nlm.nih.gov/pubmed/29263025
http://dx.doi.org/10.9745/GHSP-D-17-00296
work_keys_str_mv AT alimoazzam extendedeffectivenessoftheetonogestrelreleasingcontraceptiveimplantandthe20μglevonorgestrelreleasingintrauterinesystemfor2yearsbeyondusfoodanddrugadministrationproductlabeling
AT bahamondesluis extendedeffectivenessoftheetonogestrelreleasingcontraceptiveimplantandthe20μglevonorgestrelreleasingintrauterinesystemfor2yearsbeyondusfoodanddrugadministrationproductlabeling
AT bentlandoulsisihem extendedeffectivenessoftheetonogestrelreleasingcontraceptiveimplantandthe20μglevonorgestrelreleasingintrauterinesystemfor2yearsbeyondusfoodanddrugadministrationproductlabeling

Ejemplares similares